Chemical Formula: C18H15N3O2

Chemical Formula C18H15N3O2

Found 21 metabolite its formula value is C18H15N3O2

   

R-Benzodiazepinedione

R-Benzodiazepinedione

C18H15N3O2 (305.116421)


   
   

2,3,5,6,8,9-Hexahydro-1,5,7-triazaspiro[acephenanthrylene-10(7H),1-[2,5]-cyclohexadiene]-6,4-dione

2,3,5,6,8,9-Hexahydro-1,5,7-triazaspiro[acephenanthrylene-10(7H),1-[2,5]-cyclohexadiene]-6,4-dione

C18H15N3O2 (305.116421)


   
   

Pyrido[2,3-b][1,6]naphthyridine, 6,7,8,9-tetrahydro-7-(2-hydroxybenzoyl)- (9CI)

Pyrido[2,3-b][1,6]naphthyridine, 6,7,8,9-tetrahydro-7-(2-hydroxybenzoyl)- (9CI)

C18H15N3O2 (305.116421)


   

4-Nitro-N,N-diphenyl-1,3-benzenediamine

4-Nitro-N,N-diphenyl-1,3-benzenediamine

C18H15N3O2 (305.116421)


   

N-(2-furanylmethyl)-3-(2-furanylmethylimino)-1-isoindolamine

N-(2-furanylmethyl)-3-(2-furanylmethylimino)-1-isoindolamine

C18H15N3O2 (305.116421)


   

(R)-benzodiazepinedione

(R)-benzodiazepinedione

C18H15N3O2 (305.116421)


   

(3s)-3-(1h-Indol-3-Ylmethyl)-3,4-Dihydro-1h-1,4-Benzodiazepine-2,5-Dione

(3s)-3-(1h-Indol-3-Ylmethyl)-3,4-Dihydro-1h-1,4-Benzodiazepine-2,5-Dione

C18H15N3O2 (305.116421)


   

7-Methoxy-2-(3-methoxyanilino)-3-quinolinecarbonitrile

7-Methoxy-2-(3-methoxyanilino)-3-quinolinecarbonitrile

C18H15N3O2 (305.116421)


   

N-(3-Ethynylphenyl)-6,7-dimethoxy-4-quinazolinamine

N-(3-Ethynylphenyl)-6,7-dimethoxy-4-quinazolinamine

C18H15N3O2 (305.116421)


   

3-(1,3-Dihydrobenzimidazol-2-ylidene)-1-ethylquinoline-2,4-dione

3-(1,3-Dihydrobenzimidazol-2-ylidene)-1-ethylquinoline-2,4-dione

C18H15N3O2 (305.116421)


   

1,3-Dimethyl-6-(1-naphthalenyl)pyrrolo[3,4-d]pyrimidine-2,4-dione

1,3-Dimethyl-6-(1-naphthalenyl)pyrrolo[3,4-d]pyrimidine-2,4-dione

C18H15N3O2 (305.116421)


   

(1-Allyl-1H-benzoimidazol-2-yl)-benzo[1,3]dioxol-5-ylmethylene-amine

(1-Allyl-1H-benzoimidazol-2-yl)-benzo[1,3]dioxol-5-ylmethylene-amine

C18H15N3O2 (305.116421)


   

GN44028

GN44028

C18H15N3O2 (305.116421)


GN44028 is a potent and orally active hypoxia inducible factor (HIF)-1α inhibitor, with an IC50 of 14 nM. GN44028 inhibits hypoxia-induced HIF-1α transcriptional activity without suppressing HIF-1α mRNA expression, HIF-1α protein accumulation, or HIF-1α/HIF-1β heterodimerization. GN44028 can be used in the research of cancers[1][3].

   

(3s)-3-(1h-indol-3-ylmethyl)-3h-1,4-benzodiazepine-2,5-diol

(3s)-3-(1h-indol-3-ylmethyl)-3h-1,4-benzodiazepine-2,5-diol

C18H15N3O2 (305.116421)


   

3-(1h-indol-3-ylmethyl)-3h-1,4-benzodiazepine-2,5-diol

3-(1h-indol-3-ylmethyl)-3h-1,4-benzodiazepine-2,5-diol

C18H15N3O2 (305.116421)


   

10-{[(1e)-2-(4-hydroxyphenyl)ethenyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

10-{[(1e)-2-(4-hydroxyphenyl)ethenyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

C18H15N3O2 (305.116421)


   

10-{[(1e)-2-(4-hydroxyphenyl)ethenyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),2,4(12),7,9-pentaen-11-ol

10-{[(1e)-2-(4-hydroxyphenyl)ethenyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),2,4(12),7,9-pentaen-11-ol

C18H15N3O2 (305.116421)


   

methyl 5-{3h,4h,9h-pyrido[3,4-b]indol-1-yl}pyridine-3-carboxylate

methyl 5-{3h,4h,9h-pyrido[3,4-b]indol-1-yl}pyridine-3-carboxylate

C18H15N3O2 (305.116421)